Ensuring a trial has an independent data monitoring committee (DMC) is crucial to the safety and oversight of clinical trials. But a question this week was whether there is ever a scenario where a DMC might legitimately be deemed not to be essential 1/8
#MethodologyMonday #110
#MethodologyMonday #110
Comments
https://www.journalslibrary.nihr.ac.uk/hta/HTA9070
patients would all accrue before the DMC could provide input, where there are only v minor hazards from the treatments eg administrative studies & trials aimed at demonstrating a biologic principle 6/8
https://journals.sagepub.com/doi/epdf/10.1191/1740774504cn004rr